Literature DB >> 7402752

Modulation of the intracellular cystine content of cystinotic fibroblasts by extracellular albumin.

J G Thoene, R Lemons.   

Abstract

Cystinotic fibroblasts contain highly elevated amounts of intracellular non-protein cystine reaccumulation by cystine-depleted cystinotic fibroblasts and the steady-state cystine content of nondepleted cystinotic fibroblasts can be modulated by the addition of bovine serum albumin to the culture medium. This effect is not seen in cultures of normal and cystinotic heterozygote fibroblasts. The cystinotic homozygote cells accumulate cystine under there conditions from proteolysis of the albumin. An increased rate of pinocytosis or proteolysis of albumin does not account for the observed cystine accumulation by the cystinotic fibroblasts. Comparison of the amount of cystine accumulated to the amount of albumin degraded shows that less than one percent of the cystine moieties released by proteolysis is retained within these cells.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7402752     DOI: 10.1203/00006450-198006000-00001

Source DB:  PubMed          Journal:  Pediatr Res        ISSN: 0031-3998            Impact factor:   3.756


  15 in total

1.  Lysosomal cystine accumulation promotes mitochondrial depolarization and induction of redox-sensitive genes in human kidney proximal tubular cells.

Authors:  Rodolfo Sumayao; Bernadette McEvoy; Philip Newsholme; Tara McMorrow
Journal:  J Physiol       Date:  2016-04-10       Impact factor: 5.182

2.  Heptahelical protein PQLC2 is a lysosomal cationic amino acid exporter underlying the action of cysteamine in cystinosis therapy.

Authors:  Adrien Jézégou; Elisa Llinares; Christine Anne; Sylvie Kieffer-Jaquinod; Seana O'Regan; Joëlle Aupetit; Allel Chabli; Corinne Sagné; Cécile Debacker; Bernadette Chadefaux-Vekemans; Agnès Journet; Bruno André; Bruno Gasnier
Journal:  Proc Natl Acad Sci U S A       Date:  2012-11-20       Impact factor: 11.205

Review 3.  The renal Fanconi syndrome in cystinosis: pathogenic insights and therapeutic perspectives.

Authors:  Stephanie Cherqui; Pierre J Courtoy
Journal:  Nat Rev Nephrol       Date:  2016-12-19       Impact factor: 28.314

4.  Time course of pathogenic and adaptation mechanisms in cystinotic mouse kidneys.

Authors:  Héloïse P Gaide Chevronnay; Virginie Janssens; Patrick Van Der Smissen; Francisca N'Kuli; Nathalie Nevo; Yves Guiot; Elena Levtchenko; Etienne Marbaix; Christophe E Pierreux; Stéphanie Cherqui; Corinne Antignac; Pierre J Courtoy
Journal:  J Am Soc Nephrol       Date:  2014-02-13       Impact factor: 10.121

5.  Inhibitors of protein synthesis also inhibit lysosomal proteolysis. Studies using cystinotic fibroblasts.

Authors:  J G Thoene; R Lemons; S Boskovich; K Borysko
Journal:  J Clin Invest       Date:  1985-02       Impact factor: 14.808

6.  Protection of Cystinotic Mice by Kidney-Specific Megalin Ablation Supports an Endocytosis-Based Mechanism for Nephropathic Cystinosis Progression.

Authors:  Virginie Janssens; Héloïse P Gaide Chevronnay; Sandrine Marie; Marie-Françoise Vincent; Patrick Van Der Smissen; Nathalie Nevo; Seppo Vainio; Rikke Nielsen; Erik I Christensen; François Jouret; Corinne Antignac; Christophe E Pierreux; Pierre J Courtoy
Journal:  J Am Soc Nephrol       Date:  2019-09-23       Impact factor: 10.121

7.  Role of thiols in degradation of proteins by cathepsins.

Authors:  T Kooistra; P C Millard; J B Lloyd
Journal:  Biochem J       Date:  1982-05-15       Impact factor: 3.857

8.  Disulphide reduction in lysosomes. The role of cysteine.

Authors:  J B Lloyd
Journal:  Biochem J       Date:  1986-07-01       Impact factor: 3.857

9.  Cystine accumulation in cystinotic fibroblasts from free and protein-linked cystine but not cysteine.

Authors:  J G Thoene; R M Lemons
Journal:  Biochem J       Date:  1982-12-15       Impact factor: 3.857

10.  The effect of chloroquine on the metabolism of [35S]cystine in normal and cystinotic human skin fibroblasts.

Authors:  C J Danpure
Journal:  Biochem J       Date:  1981-12-15       Impact factor: 3.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.